GRCE

Grace Therapeutics
GRCE

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $1.55M invested in Grace Therapeutics in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$528K
2
+$253K
3
+$238K
4
VF
Virtu Financial
New York
+$118K
5
Morgan Stanley
Morgan Stanley
New York
+$37.3K

Top Sellers

1
-$3.59K
2
-$572
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$528K
2
$273K
3
$238K
4
$176K
5
$137K
6
$106K
7
$38K
8
$24K
9
$18K
10
$8K
11
$2.02K
12
$28